Alcon: in demand after Q1 results

(CercleFinance.com) - Alcon shares have jumped 9% in Zurich today, the day after the ophthalmology laboratory reported core EPS up 11% to $0.
78 (+21% at constant exchange rates) for Q1 2024.

The Swiss group improved its underlying operating margin by 1.4 point to 22% on sales of $2.44bn, up 5% (+7% at constant exchange rates), on robust sales in contact lenses and eye health.

On this basis, Alcon is maintaining its main targets for 2024, i.e. core EPS of $3 to $3.10, an underlying operating margin of 20.5% to 21.5%, and sales of $9.9bn to $10.1bn.


Copyright (c) 2024 CercleFinance.com. All rights reserved.